Santen Pharmaceutical Co., Ltd.
4536
Rang în acțiuni
#4330
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research,... Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It provides DE-114A for allergic conjunctivitis and DE-076C for vernal keratoconjunctivitis. Furthermore, DE-109 is in Phase III clinical trials for the treatment of uveitis. The company is also active in addressing myopia with DE-127, currently in Phase II/III trials in Japan and Phase III in other Asian markets, alongside STN1013400, which is in Phase I trials. For dry eye, Santen offers DE-089C, which has successfully concluded its Phase III clinical trials. In addition to its prescription portfolio, the company produces and sells various over-the-counter (OTC) pharmaceutical products. Founded in 1890 under the name Santendo Pharmaceutical Co., Ltd., the company rebranded to its current name, Santen Pharmaceutical Co., Ltd., in 1958. It is headquartered in Osaka, Japan.
Preț acțiune
$11.35
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$3.65B
Schimbare (1 zi)
1.55%
Schimbare (1 an)
-0.91%
Țară
JP
Tranzacționează Santen Pharmaceutical Co., Ltd. (4536)
Categorie
Healthcare
Capitalizarea de piață a Santen Pharmaceutical Co., Ltd.(4536)
Capitalizare de piață: $3.65B
În anul October 2026, Santen Pharmaceutical Co., Ltd. are o capitalizare de piață de $3.65B. Acest lucru face ca Santen Pharmaceutical Co., Ltd. să fie a 4330th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Santen Pharmaceutical Co., Ltd. din 2010 până în 2026
4536 în comparație cu top 5 cele mai populare stocks
